Skip to main content

Table 5 Correlation between metabolic phenotypes of stroma and clinicopathologic factors

From: Metabolic phenotypes in primary unknown metastatic carcinoma

Parameters

Glycolysis type

Glutaminolysis type

Mitochondrial type

Yes

No

p-value

Yes

No

p-value

Yes

No

p-value

n = 2 (%)

n = 75 (%)

 

n = 8 (%)

n = 69 (%)

 

n = 74 (%)

n = 3 (%)

Age

  

0.547

  

0.710

  

0.741

 <50

1 (50.0)

24 (32.0)

 

3 (37.5)

22 (31.9)

 

3 (25.0)

22 (33.8)

 

 ≥50

1 (50.0)

51 (68.0)

 

5 (62.5)

47 (68.1)

 

9 (75.0)

43 (66.2)

 

Sex

  

0.524

  

0.466

  

0.351

 Male

2 (100.0)

46 (61.3)

 

4 (50.0)

44 (63.8)

 

6 (50.0)

42 (64.6)

 

 Female

0 (0.0)

29 (38.7)

 

4 (50.0)

25 (36.2)

 

6 (50.0)

23 (35.4)

 

Clinical subtype

  

0.627

  

0.857

  

0.533

 Nodal type

1 (50.0)

33 (44.0)

 

3 (37.5)

31 (44.9)

 

5 (41.7)

29 (44.6)

 

 Single organ type

1 (50.0)

14 (18.7)

 

1 (12.5)

14 (20.3)

 

4 (33.3)

11 (16.7)

 

 Intermediate type

0 (0.0)

14 (18.7)

 

2 (25.0)

12 (17.4)

 

1 (8.3)

13 (20.0)

 

 Carcinomatosis type

0 (0.0)

14 (18.7)

 

2 (25.0)

12 (17.4)

 

2 (16.7)

12 (18.5)

 

Histologic type

  

0.050

  

0.237

  

0.049

 AD

0 (0.0)

27 (36.0)

 

5 (62.5)

22 (31.9)

 

8 (66.7)

19 (29.2)

 

 PD

2 (100.0)

14 (18.7)

 

2 (25.0)

14 (20.3)

 

2 (16.7)

14 (21.5)

 

 SQ

0 (0.0)

20 (26.7)

 

1 (12.5)

19 (27.5)

 

0 (0.0)

20 (30.8)

 

 UP

0 (0.0)

14 (18.7)

 

0 (0.0)

14 (20.3)

 

2 (16.7)

12 (18.5)

 

Organs involved

  

0.439

  

0.003

  

0.121

 Lymph node

1 (50.0)

48 (64.0)

 

4 (50.0)

45 (65.2)

 

6 (50.0)

43 (66.2)

 

 Bone

1 (50.0)

9 (12.0)

 

0 (0.0)

10 (14.5)

 

3 (25.0)

7 (10.8)

 

 Brain

0 (0.0)

9 (12.0)

 

0 (0.0)

9 (13.0)

 

0 (0.0)

9 (13.8)

 

 Other

0 (0.0)

9 (12.0)

 

4 (50.0)

5 (7.2)

 

3 (25.0)

6 (9.2)

 
  1. Bold represents p<0.05.